BPC-157 (10mg)

BPC-157 Canada: BPC-157 10mg Research Product

BPC-157 Canada researchers can order a 10mg vial directly from Red Leaf Research Labs, with published analytical information, Canadian-dollar pricing and domestic express fulfilment. A combined BPC-157 / TB-500 format is listed separately for laboratories that want both compounds in one vial.

For searches such as buy BPC-157 Canada, BPC 157 10mg or body protection compound 157, this page sets out what the vial contains, what the published literature does and does not establish, and what to check on the analytical report before ordering.

Red Leaf Research Labs supplies research material to qualified purchasers in Canada. Nothing on this page describes a therapy, a treatment or a permitted personal use.

BPC-157 10mg Research Format

BPC-157 Research Specifications

• Compound name: BPC-157
• Full name: Body protection compound 157
• Class: Synthetic pentadecapeptide — fifteen amino acids
• Amino acid sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV)
• Origin: A partial sequence of a protein identified in human gastric juice; the parent protein is where the “body protection compound” name comes from
• CAS number: 137525-51-0
• Molecular formula: C₆₂H₉₈N₁₆O₂₂
• Approximate molecular weight: 1419.5 g/mol
• Physical format: Lyophilized powder
• Available research quantity: 10mg
• Intended use: Qualified laboratory research only

What Is BPC-157?

BPC-157 is a fifteen-residue synthetic peptide corresponding to a partial sequence of a protein found in human gastric juice. It does not occur in the body in this form — the fragment was defined and synthesised by researchers, and the parent protein it derives from is the source of the “body protection compound” designation.

Its sequence is unusually proline-rich, which is the structural feature most often cited in explaining its stability in gastric conditions. That stability is the reason a good deal of the published work uses oral administration in animal models where most peptides would not survive the route.

What the BPC-157 Literature Actually Shows

This is the section a laboratory planning work with BPC-157 needs most, because the gap between how the compound is discussed online and what the published record contains is unusually wide.

The literature is substantial in volume and narrow in origin. A large proportion of the published studies come from a small number of research groups, predominantly working in rodent models, and centre on gastrointestinal lesion models, tendon and ligament healing models, and angiogenesis endpoints. Independent replication across unrelated laboratories is thinner than the total publication count suggests.

There are no completed large controlled human trials establishing efficacy or safety, and BPC-157 holds no marketing authorization in Canada or elsewhere. A rodent tendon-healing result is a rodent tendon-healing result; it does not establish an effect, a dose, or a safety profile in any person. Laboratories should design around the published endpoints rather than around the claims that circulate about them.

Why Buy BPC-157 10mg in Canada from a Domestic Research Supplier?

BPC-157 is comparatively robust for a peptide — the proline-rich sequence that gives it stability in gastric conditions also makes it forgiving in the vial. So the case for domestic supply here rests less on preventing degradation than on the two things that actually go wrong with this compound in this market.

The first is identity. BPC-157 is among the most counterfeited research peptides in circulation, and a purity figure attached to no verifiable report is worth nothing. The second is recourse: when a lot does not match its paperwork, a Canadian counterparty can be held to an answer and an offshore reseller generally cannot.

How This BPC-157 Canada Page Improves on Typical Competitor Listings

• The evidence base is described accurately, including how concentrated the source literature is — which most listings omit because it is inconvenient.
• Sequence and formula are given, so identity testing has a specific target.
• The origin is stated correctly. BPC-157 is a synthesised fragment, not a naturally occurring peptide, and the two are not the same claim.
• No outcome claims. This listing does not describe experiences, results or benefits.
• The blend alternative is cross-referenced rather than hidden, so a researcher can choose the right format.

How to Evaluate a BPC-157 Certificate of Analysis

Given how widely this compound is counterfeited, identity confirmation carries more weight here than the purity percentage everyone quotes.

1. Named molecule: BPC-157, with the GEPPPGKPADDAGLV sequence or CAS 137525-51-0 given.
2. Mass confirmation: approximately 1419.5 daltons.
3. Deletion sequences: for a proline-rich fifteen-mer these are the characteristic synthesis impurity; ask whether they were resolved.
4. Lot reference and date: cross-check both against the vial you receive.
5. Method: note which technique produced the purity number.
6. Reported quantity: should reconcile with the 10mg format.
7. Independent check: a verification reference you can put to the issuing laboratory.

Red Leaf publishes Janoshik reports with a verification key. On a compound this widely faked, a report you cannot trace to a testing laboratory is a graphic, not evidence.

BPC-157 10mg Lyophilized Research Format

The 10mg vial arrives as a lyophilized cake. Lyophilization is a drying step and carries no implication about identity or purity.

BPC-157’s proline-rich sequence gives it better-than-average stability, but that applies to the dry state and to gastric pH — not to an open vial left at room temperature or a solution stored indefinitely. Inspect the cake, connect the vial to its analytical report, and follow validated institutional procedures for storage and preparation. Background on diluent choice is in bacteriostatic water uses and handling.

Working out concentration for this vial? Our peptide reconstitution calculator converts vial size and bacteriostatic water volume into mg per mL and U-100 syringe units.

How to Buy BPC-157 in Canada for Qualified Research

1. Establish eligibility. Confirm the purchaser and institution are authorized to hold research-use material.
2. Read the report first — and on this compound in particular, confirm it is traceable to a named testing laboratory.
3. Choose the format. This single-compound vial, or the BPC-157 / TB-500 blend if the design calls for both.
4. Confirm the destination can receive and store the vial.
5. Log it in. Lot reference, arrival condition, storage location, against the study plan.

Fulfilment is to qualified Canadian purchasers by domestic express. Red Leaf supplies material and documentation; it does not advise on study design and provides nothing that supports use in humans or animals.

BPC-157 Availability in Canada: Research vs. Consumer Searches

BPC-157 holds no marketing authorization in Canada and has not been assessed for consumer safety or effectiveness by Health Canada. It has also drawn regulatory attention elsewhere: in the United States the FDA moved to restrict its use in compounding, which is a meaningful signal about how regulators view the current evidence.

Research supply and public medical availability are separate categories. A vial available to a qualified laboratory is not an approved retail medicine, a recovery product, or a substitute for professional care. Anyone searching from a personal injury concern should speak with a licensed clinician rather than a research supplier.

BPC-157 10mg Canada Procurement Checklist

Explore BPC-157 Research Information

For supplier-selection criteria in the Canadian market, review how to evaluate a Canadian research peptide supplier. For a wider survey of compounds studied in repair and growth signalling, see peptides studied in muscle-growth research.

BPC-157 research FAQ

Is BPC-157 a naturally occurring peptide?

No. It is a synthesised fifteen-residue fragment corresponding to part of a protein found in human gastric juice. The fragment itself does not occur in the body in that form.

How strong is the evidence base?

Substantial in volume, narrow in origin. Most published work is rodent, from a relatively small number of groups, with limited independent replication and no completed large controlled human trials.

Why is the sequence proline-rich?

That feature is most often cited in explaining its stability under gastric conditions, which is why much of the animal literature uses oral administration.

Is BPC-157 approved anywhere?

No. It holds no marketing authorization in Canada, and US regulators have moved to restrict its use in compounding.

Does Red Leaf Research Labs provide dosing information?

No. Red Leaf Research Labs supplies research material and analytical documentation only.

Research use only. BPC-157 supplied by Red Leaf Research Labs is intended for qualified laboratory research. It is not a medicine, not for human or veterinary use, and not for diagnostic or therapeutic application.